Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data? Remon J, Lopez A, Planchard D, Besse B, et al. Eur J Cancer 2023;195:113369.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Remon J, Lopez A, Planchard D, Besse B, et al. Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data? Eur J Cancer 2023;195:113369.
PMID: 37913681